Page 134 - Read Online

An et al. Hepatoma Res 2023;9:43 https://dx.doi.org/10.20517/2394-5079.2023.60 Page 11 of 12

31. Bargellini I, Mosconi C, Pizzi G, et al. Yttrium-90 radioembolization in unresectable intrahepatic cholangiocarcinoma: results of a
multicenter retrospective study. Cardiovasc Intervent Radiol 2020;43:1305-14. DOI
32. Al-Adra DP, Gill RS, Axford SJ, Shi X, Kneteman N, Liau SS. Treatment of unresectable intrahepatic cholangiocarcinoma with
yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol 2015;41:120-7. DOI PubMed PMC
33. Gangi A, Shah J, Hatfield N, et al. Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere
radioembolization: results of a single institution retrospective study. J Vasc Interv Radiol 2018;29:1101-8. DOI PubMed PMC
34. Mouli S, Memon K, Baker T, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival
analysis. J Vasc Interv Radiol 2013;24:1227-34. DOI PubMed PMC
35. Gupta AN, Gordon AC, Gabr A, et al. Yttrium-90 radioembolization of unresectable intrahepatic cholangiocarcinoma: long-term
follow-up for a 136-patient cohort. Cardiovasc Intervent Radiol 2022;45:1117-28. DOI
36. Riaz A, Awais R, Salem R. Side effects of yttrium-90 radioembolization. Front Oncol 2014;4:198. DOI PubMed PMC
37. Sangro B, Iñarrairaegui M, Bilbao JI. Radioembolization for hepatocellular carcinoma. J Hepatol 2012;56:464-73. DOI PubMed
38. Young JY, Rhee TK, Atassi B, et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization
treatments for hepatocellular carcinoma. J Vasc Interv Radiol 2007;18:1375-82. DOI
39. Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible
risk factors. Cancer 2008;112:1538-46. DOI
40. Mosconi C, Solaini L, Vara G, et al. Transarterial chemoembolization and radioembolization for unresectable intrahepatic
cholangiocarcinoma-a systemic review and meta-analysis. Cardiovasc Intervent Radiol 2021;44:728-38. DOI PubMed
41. Gonsalves CF, Brown DB. Chemoembolization of hepatic malignancy. Abdom Imaging 2009;34:557-65. DOI PubMed
42. Gusani NJ, Balaa FK, Steel JL, et al. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial
chemoembolization (TACE): a single-institution experience. J Gastrointest Surg 2008;12:129-37. DOI
43. Kiefer MV, Albert M, McNally M, et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin,
mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer 2011;117:1498-505. DOI
44. Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol 2013;30:3-11. DOI
PubMed PMC
45. Lencioni R, de Baere T, Burrel M, et al. Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC bead
(DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 2012;35:980-5. DOI PubMed PMC
46. Venturini M, Sallemi C, Agostini G, et al. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs
doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study. Br J Radiol
2016;89:20160247. DOI
47. Herber S, Otto G, Schneider J, et al. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.
Cardiovasc Intervent Radiol 2007;30:1156-65. DOI
48. Vogl TJ, Naguib NN, Nour-Eldin NE, et al. Transarterial chemoembolization in the treatment of patients with unresectable
cholangiocarcinoma: results and prognostic factors governing treatment success. Int J Cancer 2012;131:733-40. DOI
49. Ge Y, Jeong S, Luo GJ, et al. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent
unresectable intrahepatic cholangiocarcinoma: development of a prognostic nomogram. Hepatobiliary Pancreat Dis Int 2020;19:138-
46. DOI
50. Burger I, Hong K, Schulick R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience
in a single institution. J Vasc Interv Radiol 2005;16:353-61. DOI
51. Park SY, Kim JH, Yoon HJ, Lee IS, Yoon HK, Kim KP. Transarterial chemoembolization versus supportive therapy in the palliative
treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol 2011;66:322-8. DOI PubMed
52. Kim JH, Yoon HK, Sung KB, et al. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic
cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 2008;113:1614-22. DOI PubMed
53. Schiffman SC, Metzger T, Dubel G, et al. Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic
cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol 2011;18:431-8. DOI
54. Aliberti C, Benea G, Tilli M, Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-
release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 2008;31:883-8. DOI PubMed
55. Liu D, Wang J, Ma Z, et al. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with
irinotecan-eluting beads: analysis of efficacy and safety. Cardiovasc Intervent Radiol 2022;45:1092-101. DOI
56. Zhou TY, Zhou GH, Zhang YL, et al. Drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres for
treatment of unresectable intrahepatic cholangiocarcinoma. J Cancer 2020;11:4534-41. DOI PubMed PMC
57. He M, Jiang N, Yin X, Xu A, Mu K. Conventional and drug-eluting beads transarterial chemoembolization in patients with
unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis. J Cancer Res Clin Oncol 2023;149:531-40.
DOI
58. Wang J, Xue Y, Liu R, et al. DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a
prospective clinical study. Front Bioeng Biotechnol 2022;10:1112500. DOI PubMed PMC
59. Scheuermann U, Kaths JM, Heise M, et al. Comparison of resection and transarterial chemoembolisation in the treatment of advanced
intrahepatic cholangiocarcinoma--a single-center experience. Eur J Surg Oncol 2013;39:593-600. DOI PubMed
60. Lee DD, Croome KP, Musto KR, et al. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl 2018;24:634-44. DOI